CEA-ROCHE(R) EIA

FDA Premarket Approval P840027

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

DeviceCEA-ROCHE(R) EIA
Generic NameSystem, Test, Carcinoembryonic Antigen
ApplicantROCHE DIAGNOSTICS GMBH
Date Received1984-06-19
Decision Date1985-05-13
Notice Date1985-06-12
PMAP840027
SupplementS
Product CodeDHX 
Docket Number85M-0253
Advisory CommitteeImmunology
Expedited ReviewNo
Combination Product No
Applicant Address ROCHE DIAGNOSTICS GMBH 1080 U.s. Hwy. 202 branchburg Township somerville, NJ 08876-3771

Supplemental Filings

Supplement NumberDateSupplement Type
P840027Original Filing
S006 1989-04-11 Normal 180 Day Track
S005 1989-04-11 Normal 180 Day Track
S004 1988-10-27 Normal 180 Day Track
S003 1988-05-17 Normal 180 Day Track
S002 1986-08-19 Normal 180 Day Track
S001 1986-06-17 Special (immediate Track)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.